Walleye Capital
ASND icon

Walleye Capital’s Ascendis Pharma A/S ASND Stock Holding History

Walleye Capital’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Sell
800
-1,800
-69% -$420K ﹤0.01% 3457
2026
Q1 		$595K Sell
2,600
-200
-7% -$44.8K ﹤0.01% 2518
2025
Q4 		$597K Buy
2,800
+2,500
+833% +$516K ﹤0.01% 2844
2025
Q3 		$59.6K Buy
300
+200
+200% +$37.3K ﹤0.01% 3940
2025
Q2 		$17.3K Sell
100
-500
-83% -$81.4K ﹤0.01% 4255
2025
Q1 		$93.5K Buy
+600
New +$85.7K ﹤0.01% 3654
2024
Q3 		– Sell
-1,700
Closed -$232K – 5259
2024
Q2 		$232K Sell
1,700
-100
-6% -$13.6K ﹤0.01% 4190
2024
Q1 		$272K Sell
1,800
-700
-28% -$99.9K ﹤0.01% 3743
2023
Q4 		$315K Sell
2,500
-600
-19% -$59.8K ﹤0.01% 3339
2023
Q3 		$290K Buy
+3,100
New +$290K ﹤0.01% 3264
2023
Q2 		– Sell
-4,400
Closed -$472K – 4293
2023
Q1 		$472K Sell
4,400
-1,100
-20% -$126K 0.01% 1762
2022
Q4 		$672K Buy
5,500
+4,200
+323% +$488K 0.01% 1250
2022
Q3 		$134K Buy
+1,300
New +$123K ﹤0.01% 2298

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Walleye Capital's ASND Position: Q2 2026 in Review

Walleye Capital increased its Ascendis Pharma A/S (ASND) stake by 340,454% in Q2 2026, buying an estimated $29.4M and bringing the position to 126,005 shares worth $33.6M. The position accounts for 0.12% of the portfolio, ranked #118.

Walleye Capital first reported a position in ASND in Q4 2023 and has held it in 9 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Walleye Capital held 126,005 shares of Ascendis Pharma A/S worth $33.6M as of Q2 2026.
  • Walleye Capital bought 125,968 Ascendis Pharma A/S shares in Q2 2026, an estimated $29.4M.
  • Ascendis Pharma A/S made up 0.12% of Walleye Capital's portfolio in Q2 2026, its #118 holding.
  • Walleye Capital first reported a position in Ascendis Pharma A/S in Q4 2023 and has held it in 9 quarters since.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.